Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Corticobasal Degeneration (CBD) clinical trials
3 of 4 indexed Corticobasal Degeneration (CBD) trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Corticobasal Degeneration (CBD): 4 US clinical trials tracked, 3 recruiting.
Corticobasal Degeneration (CBD) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Jennifer Whitwell, running 1 of these trials.
Enrollment posture brief
Registry condition corticobasal-degeneration-cbd
OPEN 3 | RECR 75% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Corticobasal Degeneration (CBD) lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Corticobasal Degeneration (CBD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Corticobasal Degeneration (CBD) is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Mayo Clinic
NCT04363684
The CurePSP Genetics Program
Massachusetts General Hospital
NCT06647641
Imaging Studies in Corticobasal Syndrome
Jennifer Whitwell
NCT07000851
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
University of California, San Francisco
NCT02966145
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Corticobasal Degeneration (CBD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Corticobasal Degeneration (CBD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Corticobasal Degeneration (CBD) page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Corticobasal Degeneration (CBD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jennifer Whitwell sponsors the most Corticobasal Degeneration (CBD) trials on record, review their full trial history before evaluating a specific study. See Jennifer Whitwell's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Corticobasal Degeneration (CBD) condition card totals 4 registered trials; most-linked intervention AV1451 Tau; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.